Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: thinking of making a change

Posted by phidippus on October 28, 2017, at 14:36:10

In reply to thinking of making a change, posted by Melusine on October 28, 2017, at 10:13:40

Its hard to suggest anything when we don't know what you're on or what you've been on.

Buprenorphine, a partial mu opioid agonist commonly used in addiction treatment, may also play a future role in helping patients with treatment-resistant depression. One randomized study of 88 patients found that those who took very low doses of buprenorphine for 2 or 4 weeks had significantly lower scores on the Beck Suicide Ideation Scale, compared with their counterparts on placebo.

Drugs with anti-inflammatory properties may also have a role. One study of 60 patients found that the tumor necrosis factoralpha antagonist infliximab may benefit patients with treatment-resistant depression who have high inflammatory biomarkers at baseline

Riluzole is associated with antidepressant effects in patients with treatment-resistant depression, according to results of an open-label study reported in the January issue of the American Journal of Psychiatry. Riluzole is a glutamate-modulating agent currently approved by the U.S. Food and Drug Administration for the treatment of amyotrophic lateral sclerosis.

Scopalamine is another agent that can be trialed.





Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:phidippus thread:1095641